CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

A genetic shield: new technique protects optic nerve cells

Scientists have shown that a form of gene therapy preserves vision in a mouse model of glaucoma

Blue DNA

US scientists have highlighted the potential of gene therapy to protect optic nerve cells and preserve vision in a mouse model of glaucoma.

Reporting their findings in Cell, researchers showed that activating the CaMKII using gene therapy protected retinal ganglion cells.

Among mice that received gene therapy, 77% of retinal ganglion cells survived after one year compared to 8% of retinal ganglion cells in control mice.

Increasing retinal ganglion cell survival rates translated into a greater likelihood of preserved visual function.

Three visual-behavioural tests confirmed superior visual function in the mice treated with gene therapy.

Dr Bo Chen, an associate professor of ophthalmology and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, highlighted the potential of the findings.

"If we make retinal ganglion cells more resistant and tolerant to the insults that cause cell death in glaucoma, they might be able to survive longer and maintain their function."